Mirikizumab
- Commodity name： Mirikizumab
Details Description
- Product Description
-
Product Parameters
Product Number XC978996-100µg English Name Mirikizumab Chinese Name 米吉珠单抗 Antibody Source Human Clone Type Monoclonal State Liquid Concentration 1mg/mL Subtype IgG4κ Expression System CHO-K1 stable cell line Purification Method Affinity purified by Protein A Buffer 0.2 μm filtered in PBS, pH 7.4, 10% glycerol Purity ＞98% as determined by SDS-PAGE；＞98% as determined by SEC-HPLC Storage Conditions
Aliquot and store at -20°C to -80°C,Avoid repeat freeze-thaw cycles.
Notes
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
Product Introduction
Mirikizumab is a humanized anti-IL -23p19 IgG4 monoclonal antibody developed as a treatment for ulcerative colitis (UC) and Crohn’s disease. It targets interleukin-23 (IL-23) and binds to the p19 subunit of IL-23, a cytokine that plays a key role in promoting inflammation in autoimmune diseases. By inhibiting the binding of IL-23 to IL-23R, Mirikizumab helps reduce the inflammatory response, which is central to conditions like ulcerative colitis and Crohn's disease.
Documents
Keywords:
Reference Drug | Antibody Drug | Instrument | Reagent
Related Products
Recombinant human IFN gamma protein (his-tag)
Product Number: XC989997-500µg English Name: Recombinant Human IFN gamma Protein Chinese Name: 重组人 IFN gamma 蛋白
View DetailsRecombinant human IFN gamma protein (no tag)
Product Number: XC989996-500µg English Name: Recombinant Human IFN gamma Protein Chinese Name: 重组人 IFN gamma 蛋白
View DetailsWelcome your message
Subscription Information
We will send you real-time information regularly!
Shanghai Constream biotechnology Co., Ltd.
Tel: 021-59255902
Address: 3rd Floor, Building 28, No. 10688, Beiqing Highway, Qingpu District, Shanghai
Mobile Website
Official Account
Copyright © 2024 Shanghai Constream biotechnology Co., Ltd